Zalcitabine

In the US, Zalcitabine (zalcitabine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF03

CAS registry number (Chemical Abstracts Service)

0007481-89-2

Chemical Formula

C9-H13-N3-O3

Molecular Weight

211

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

Nucleoside reverse transcriptase inhibitor (NRTI)

Chemical Name

2', 3'-Dideoxycytidine

Foreign Names

  • Zalcitabinum (Latin)
  • Zalcitabin (German)
  • Zalcitabine (French)
  • Zalcitabina (Spanish)

Generic Names

  • Zalcitabine (OS: BAN, USAN)
  • ddC (IS)
  • NSC 606170 (IS)
  • Ro 24-2027/000 (IS)
  • Zalcitabine (PH: USP 34)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)